Snake Venom Phospholipases A2: A New Class of Antitumor Agents
Journal:
Protein & Peptide Letters
Volume:
16
Page:
894-898
Author(s):
Renata S. Rodrigues, Luiz Fernando M. Izidoro, Robson J. de Oliveira Jr., Andreimar M. Soares, Veridiana M. Rodrigues and Suely V. Sampaio
The Role of Proteomics in Osteoarthritis Pathogenesis Research
Journal:
Current Drug Targets
Volume:
10
Page:
543-556
Author(s):
Cristina Ruiz-Romero and Francisco J. Blanco
Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
397-414
Author(s):
K. L. Vine, L. Matesic, J. M. Locke, M. Ranson and D. Skropeta
Chitinases: Biomarkers for Human Diseases
Journal:
Protein & Peptide Letters
Volume:
16
Page:
490-498
Author(s):
Shou-Ping Guan, Yu-Keung Mok, Khai-Nee Koo, Kai-Ling Chu and W.S. Fred Wong
Cartilage and Bone Extracellular Matrix
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
1334-1348
Author(s):
Chiara Gentili and Ranieri Cancedda
Cyclodepsipeptides - Potential Drugs and Lead Compounds in the Drug Development Process
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
1122-1137
Author(s):
R. Lemmens-Gruber, M. R. Kamyar and R. Dornetshuber
Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
940-952
Author(s):
Francesca Santilli, Natale Vazzana, Loredana G. Bucciarelli and Giovanni Davi
Targeting the Tumor Stroma in Cancer Therapy
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
185-191
Author(s):
Kevin Anton and John Glod
The Discovery of Antiangiogenic Molecules: A Historical Review
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
345-352
Author(s):
Domenico Ribatti
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
32-71
Author(s):
Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti and Massimino D'Armiento